Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

European glucose monitoring market set to double by 2016

This article was originally published in Clinica

Executive Summary

Europe’s continuous glucose monitoring (CGM) market will more than double by 2016, analysts Frost & Sullivan believe. This growth is in response primarily to the increasing demand for an easy-to-use and patient-friendly glucose-monitoring device. The segment will generate revenues totalling $52m in 2016, up from an estimated $23.5m in 2009, according to the report European Market for Continuous Glucose Monitoring, which covers the Benelux countries, France, Germany, Italy, Scandinavia, Spain and the United Kingdom.